This hypothesis has been supported by the observation of increased penetration of [14C] doxorubicin through drug-resistant MCCs (PgP overexpressing) compared to drug-sensitive MCCs (wild-type) [20]; inhibitors of PgP stimulated cellular accumulation of drugs, but resulted in reduced penetration through tumor tissue in this model [20]. The gene discussed is PGP; the disease is neoplasm.